Bartlett D L, Fong Y, Fortner J G, Brennan M F, Blumgart L H
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Ann Surg. 1996 Nov;224(5):639-46. doi: 10.1097/00000658-199611000-00008.
The surgical management of gallbladder cancer is controversial. There is no consensus among surgeons as to the indications for reoperation or radical resection.
The purpose of this study was to examine results of reoperation after an incidental finding of gallbladder cancer after cholecystectomy, and results of radical resection in patients with advanced disease.
A retrospective review of 149 patients with the diagnosis of gallbladder cancer treated from 1985 to 1993 was performed. Fifty-eight patients were explored and 23 underwent resection for cure. Resection included trisegmentectomy in nine patients and bile duct resection in ten patients. Seventeen patients underwent re-exploration after an incidental finding of gallbladder cancer at initial cholecystectomy.
Surgical resection is associated with an actuarial 51% 5-year disease-free survival rate, with a median follow-up time of 48 months. Eight patients are alive beyond 50 months. There were no operative deaths; the perioperative morbidity rate was 26%. Nodal status is the most powerful predictor of outcome. Two patients with T4, NO disease are alive without evidence of disease beyond 4 years. Thirteen of the 17 patients (76%) undergoing reoperation after simple cholecystectomy for T2 or T3 tumors had residual disease.
Patients with nodal metastasis beyond the pericholedochal nodes should not be considered for curative resection. Tumors staged T4, NO should be included with stage III disease, and resection should be considered. Re-resection of T2 or T3 tumors after simple cholecystectomy is likely to include residual disease and should thus provide the only chance for long-term survival.
胆囊癌的手术治疗存在争议。外科医生对于再次手术或根治性切除的指征尚无共识。
本研究的目的是探讨胆囊切除术后偶然发现胆囊癌的再次手术结果,以及晚期疾病患者的根治性切除结果。
对1985年至1993年治疗的149例胆囊癌患者进行回顾性研究。58例患者接受了探查,23例接受了根治性切除。切除包括9例患者的三段肝切除术和10例患者的胆管切除术。17例患者在初次胆囊切除术中偶然发现胆囊癌后接受了再次探查。
手术切除与5年无病生存率为51%相关,中位随访时间为48个月。8例患者存活超过50个月。无手术死亡;围手术期发病率为26%。淋巴结状态是预后的最强预测因素。2例T4、NO期患者存活,4年以上无疾病证据。17例因T2或T3肿瘤在单纯胆囊切除术后接受再次手术的患者中,13例(76%)有残留疾病。
肝门周围淋巴结以外有淋巴结转移的患者不应考虑进行根治性切除。T4、NO期肿瘤应归入III期疾病,应考虑进行切除。单纯胆囊切除术后对T2或T3肿瘤进行再次切除可能会有残留疾病,因此应是长期生存的唯一机会。